Article and Video CATEGORIES

Cancer Journey

Search By

Search here for cancer terms and phrases within cancerGRACE.org, and find tons of great information available on the GRACE website.

ABOUT
Howard (Jack) West, MD
Howard Jack West, MD, Founder, Board President

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Read More
Dr. Leighl's Highlights in Lung Cancer, 2012: ALK- and ROS1-positive NSCLC
Dr West
Author
Howard (Jack) West, MD

ALK positiveDr. Leighl, lung cancer expert from Princess Margaret Hospital in Toronto, continued her summary of the leading highlights in lung cancer from 2012 with coverage of new information on XALKORI for patients with either an ALK rearrangement or the newly identified ROS-1 rearrangement.  

The video and audio versions of the podcast on this part of her program are below, along with the figures:

[powerpress]

Dr. Leighl Highlights in LC 2012 Pt 2 ALK and ROS Rearr NSCLC Audio Podcast

Dr. Leighl Highlights in LC 2012 Pt 2 ALK and ROS Rearr NSCLC Figs

More of her presentation coming very soon!

Tags
Advanced NSCLC
ALK mutation
ALK Rearrangement
crizotinib
EML4-ALK
Highlights in Lung Cancer 2012
HSP90 inhibition
LDK378
Lung Cancer
Natasha Leighl
Princess Margaret Hospital
ROS-1
ROS1
ROS1 rearrangement
University of Toronto
XALKORI

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation

Next Previous link

Previous PostNext Post

Related Content

What is the AVO treatment for Chronic Lymphocytic Leukemia (CLL)? Acalabrutinib, Venetoclax, Obinutuzumab for High-Risk Patients
Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Targeted Therapies 2025
Targeted Therapies in Lung Cancer Patient Forum
Video
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
2025 Foro de Pacientes de Terapias Dirigidas de Cancer de Pulmon
Article
Da click aquí para más información y para registrarte ahora

Forum Discussions

Recent Comments

JOIN THE CONVERSATION
Comparing which scan for swelling above clavicle and near throat - supraclavicular lymph nodes?
Hi Hopish hope,  Welcome to…
By JanineT GRACE … on
Comparing which scan for swelling above clavicle and near throat - supraclavicular lymph nodes?
colon cancer and HIV
By Hopish hope on
Targeted Therapies in Lung Cancer March 2025
Thank you for sharing
By LeviDrake on
Multiple EGFR mutation lung cancer
Hi bluesun,I don't know of…
By JanineT GRACE … on